
Nuclasta 60mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Denosumab (60mg)
Overview Nuclasta 60mg Injection
For postmenopausal women and fracture-prone men, the 60mg Nuclasta injection combats osteoporosis. It strengthens bones, lowering fracture risk. Administered by a healthcare provider, self-injection is strictly prohibited. Consistent daily use maximizes effectiveness; complete the prescribed course, regardless of symptom improvement. Calcium and vitamin D supplementation enhances its efficacy. Common side effects may include headache, limb pain, musculoskeletal and nerve pain, constipation, and rash. Persistent or worsening side effects warrant medical consultation; management strategies are available. Prior to commencing treatment, inform your doctor of all other medications. Pregnant and breastfeeding individuals should seek medical advice before use.
Uses of Nuclasta 60mg Injection
Brittle bone disease
Major Benefits of Nuclasta 60mg Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Nuclasta 60mg Injection:
- Musculoskeletal (bone, muscle or joint) pain
- Pain in extremities
- Nerve pain
- Constipation
- Rash
- Headache
How to use Nuclasta 60mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Nuclasta 60mg Injection works:
Neulasta 60mg, a monoclonal antibody injection, counteracts a bone-resorbing protein, promoting bone strength and reducing fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Nuclasta 60mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyUNSAFE
Administering Nuclasta 60mg Injection during pregnancy carries a substantial risk. Pregnant individuals should consult their physician; research in animals and pregnant women reveals considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Administration of 60mg Nuclasta Injection while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 60mg Nuclasta injection.
KidneyCAUTION
Pegfilgrastim (60mg) injection requires careful administration in individuals with significant renal impairment. Dosage modification for Pegfilgrastim (60mg) injection may be necessary. Physician consultation is advised.
LiverCAUTION
Pegfilgrastim (60mg) injection requires careful administration in individuals with significant hepatic impairment. Dosage modification of pegfilgrastim (60mg) injection may be necessary. Physician consultation is advised.
What if you forget to take Nuclasta 60mg Injection :
Omit a Nuclasta 60mg Injection dose? Seek your physician's advice.
Facts to Know About Nuclasta 60mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
